GNN0.F
GN Store Nord A/S

Healthcare · Medical Devices · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value

658.14M USD

Market Cap

2.36B USD

Margin of Safety

-259.0%

Intrinsic / Market Ratio

0.28×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

321.27M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

648.79M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

1.00B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

658.14M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

658.14M USD

from the sum above

Market Cap

2.36B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.28×

the ratio the screener ranks by; Margin of Safety -259.0% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 321.27M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)1.81B USD
−②Net Debt Today1.49B USD
+③Growth Value0 USD
=Value321.27M USD

EPV of the Operations (NOPAT over WACC)

1.81B USD

Net debt today

-1.49B USD

Growth Value

0 USD

Value

321.27M USD

①EPV (earnings power value)

1.81B USD

②Net Debt Today

1.49B USD

③Growth Value

0 USD

Market value

Market Cap2.36B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-635.4%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 648.79M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE284.18M USD
+②Equity at Year 15, Today364.61M USD
=Value648.79M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment rising to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

284.18M USD

②Equity at Year 15, Today

364.61M USD

Market value

Market Cap2.36B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-264.2%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 1.00B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF1.58B USD
+②Invested Capital at Year 15, Today918.02M USD
−③Net Debt Today1.49B USD
=Value1.00B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment rising to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

1.58B USD

②Invested Capital at Year 15, Today

918.02M USD

③Net Debt Today

1.49B USD

Market value

Market Cap2.36B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-135.2%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 8.71%
Cost of Equity =Risk-Free Rate 4.50%+Beta 1.35×Market Risk Premium 6.00%= 12.61%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 32.12M USDPretax Income 143.90M USD= 22.32%

The tax the interest saves.

Interest Expense =EBIT 206.25M USD−Pretax Income 143.90M USD= 62.35M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 62.35M USDTotal Debt 1.61B USD×(1 − Tax Rate for WACC 22.32%)= 3.00%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 1.61B USDMarket Cap + Total Debt 2.36B USD + 1.61B USD= 40.57%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 59.43%×Cost of Equity 12.61%+Debt Weight 40.57%×Cost of Debt 3.00%= 8.71%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 4.52B USD − Total Liabilities 2.95B USD = Book Value Today 1.57B USD

Total Debt 1.61B USD − Cash and Short-Term Investments 123.27M USD = Net Debt Today 1.49B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-0.0%at most 5%passes145,612,536 / 145,612,715
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets7.0%at least -10.0%passes(421.31M USD − 102.81M USD) ÷ 4.52B USD
Price to bookMarket Cap ÷ Book Value Today1.50×at most 3×passes2.36B USD ÷ 1.57B USD
Operating marginOperating Income ÷ Revenue9.5%above 10.0%does not pass251.59M USD ÷ 2.64B USD
Revenue growthRevenue ÷ Revenue a Year Before − 15.2%above 10.0%does not pass2.64B USD / 2.51B USD
Net cash(Cash − Total Debt) ÷ Market Cap-63.1%above -30%does not pass(123.27M USD − 1.61B USD) ÷ 2.36B USD
Operating efficiencyOperating Income ÷ Gross Profit17.5%above 25.0%does not pass251.59M USD ÷ 1.44B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

43.44 EUR

Enterprise value

11.80B EUR

the provider's own figure

EV / EBITDA

9.05×

Price / book

1.53×

the provider's book

Price / earnings

—

Return on equity

2.1%

the provider's figure, not this page's

Profit margin

-3.4%

Revenue growth

-5.7%

Analyst target, mean

—

Analysts

—

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2022202320242025
Income statement

Revenue

2.68B2.69B2.51B2.64B

Gross profit

1.31B1.33B1.34B1.44B

Operating income

160.73M140.17M249.73M251.59M

EBITDA

operating income before depreciation and amortisation

350.89M356.45M435.64M416.59M

Pretax income

104.05M50.98M190.09M143.90M

Net income

73.33M33.89M138.00M102.81M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

114.51M31.35M141.69M70.02M

R&D

201.64M229.80M208.25M229.87M
Balance sheet, year end

Total assets

4.39B4.55B4.28B4.60B

Total liabilities

3.41B3.13B2.76B2.89B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

975.89M1.43B1.51B1.72B

Total debt

2.33B2.01B1.60B1.70B

Cash and equivalents

142.08M321.37M136.88M176.18M

Net PP&E

fixed assets after depreciation

180.11M153.99M151.96M167.99M

Working capital

current assets less current liabilities

-339.84M-811.30M164.39M208.45M
Cash flow

Operating cash flow

89.98M392.12M380.61M421.31M

Capital expenditure

paid out, so below zero

-239.38M-212.86M-196.10M-242.30M

Depreciation and amortisation

220.15M257.00M192.61M210.34M

Free cash flow

operating cash flow plus capital expenditure

-149.40M179.26M184.51M179.01M